Decheng Capital Leads $45M Series C Round In Chinese Biopharmaceutical Firm KeChow Pharma

For Digital Subscribers Only

Shanghai KeChow Pharma, a Chinese biopharmaceutical company focused on novel drug discover, has raised US$45million in a series C round of financing led by Decheng Capital.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

RELATED NEWS



LEAVE A REPLY